
Paradigm and Daraxonrasib in NSCLC
Sep 3, 2026 - 00:14:31
Radio and PodcastLive Radio & Podcasts
This week's episode covers some updates in small cell lung cancer, chemotherapy-induced nausea/vomiting (CINV), SC administration of isatuximab, and Lu-177 vipivotide tetraxetan. Download the Oncology Learning Companion: